Pregnancy and Fetal Outcomes After Exposure to Mefloquine in the Pre- and Periconception Period and During Pregnancy
Open Access
- 10 April 2012
- journal article
- research article
- Published by Oxford University Press (OUP) in Clinical Infectious Diseases
- Vol. 54 (11), e124-e131
- https://doi.org/10.1093/cid/cis215
Abstract
Background. Pregnant women who travel to malarious areas and their clinicians need data on the safety of malaria chemoprophylaxis. Methods. The effect of exposure to mefloquine on pregnancy and offspring outcomes was evaluated using the F. Hoffmann–La Roche global drug safety database for the time frame 31 January 1986 through 26 October 2010. We investigated pregnancy and fetal outcomes in maternal, paternal, and both-parent exposure cases with a focus on congenital malformations and fetal loss. The main outcome measures were birth defect prevalence and types of malformations. Results. A total of 2506 cases of mefloquine exposure during pregnancy or in the pre- and periconception period were evaluated. Most cases were maternal prospective (outcome of the pregnancy unknown at the time of reporting; n = 2246 [89.6%]) followed by maternal retrospective cases (outcome of the pregnancy known at the time of reporting; n = 227 [9.0%]), with small numbers of paternal and both-parent exposure cases. Of the total 2246 mefloquine maternal prospective exposures (95.2%), 2139 occurred before conception and/or during the first trimester. Of 1383 maternal prospective cases with known outcome, 978 (70.7%) resulted in delivery, 405 (29.3%) resulted in abortion (112 spontaneous, 293 therapeutic), and 43 resulted in birth defects, corresponding to a birth defect prevalence of 4.39% (43 of 978). Prospective cases overall showed no specific pattern of birth malformations. Conclusions. The drug safety database analysis of mefloquine exposure in pregnancy showed that the birth defect prevalence and fetal loss in maternal, prospectively monitored cases were comparable to background rates.Keywords
This publication has 27 references indexed in Scilit:
- Human teratogens: Update 2010Birth Defects Research Part A: Clinical and Molecular Teratology, 2011
- The position of mefloquine as a 21st century malaria chemoprophylaxisMalaria Journal, 2010
- Alternatives for Malaria Prophylaxis During the First Trimester of Pregnancy: Our Personal ViewJournal of Travel Medicine, 2010
- Insecticide-treated bed nets and curtains for preventing malariaCochrane Database of Systematic Reviews, 2004
- Maternal age and fetal loss: population based register linkage studyBMJ, 2000
- Mefloquine Prophylaxis Prevents Malaria during Pregnancy: A Double-Blind, Placebo-Controlled StudyThe Journal of Infectious Diseases, 1994
- Bed nets for the prevention of malaria and anaemia in pregnancyTransactions of the Royal Society of Tropical Medicine and Hygiene, 1993
- Mefloquine prophylaxis against malaria for female travellers of childbearing ageThe Lancet, 1992
- Mefloquine antimalarial prophylaxis in pregnancy: dose finding and pharmacokinetic study.British Journal of Clinical Pharmacology, 1990
- Safety of chloroquine in chemosuppression of malaria during pregnancy.BMJ, 1985